Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15080636 | 0.91 | — | — | |
| SCHEMBL6188463 | 0.83 | TP53 (0.39) | MEN1KMT2A | |
| SCHEMBL11309108 | 0.81 | SLC15A1 (0.41) | — | |
| SCHEMBL9400688 | 0.81 | ATM (0.39) | ALDH1A1 | |
| SCHEMBL15274732 | 0.80 | — | — | |
| SCHEMBL15080637 | 0.78 | TDP1 (0.38) | — | |
| SCHEMBL2775 | 0.74 | GAA (0.37) | GAAALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL2608298 | 0.74 | — | — | |
| SCHEMBL29342177 | 0.74 | CETP (0.32) | GAAALDH1A1 | |
| SCHEMBL11304900 | 0.73 | SLC7A5 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170137548-A1 | POLYMER COMPOUND FOR MEDICAL USE AND COMPOSITION AND DEVICE USING SAME | NATIONAL UNIVERSITY CORPORATION YAMAGATA UNIVERSIT Y (JP) | 2017-05-18 | — | — | US | disclosed |
| EP-3124507-A1 | POLYMER COMPOUND FOR MEDICAL USE AND COMPOSITION AND DEVICE USING SAME | National University Corporation Yamagata University (JP) | 2017-02-01 | — | — | EP | disclosed |
| US-20130252883-A1 | Macrocycles and Their Uses | NOVARTIS AG (CH) | 2013-09-26 | — | — | US | disclosed |
| US-8476224-B2 | Macrocycles and their uses | NOVARTIS AG (US) | 2013-07-02 | — | — | US | disclosed |
| US-8476224-B2 | Macrocycles and their uses | NOVARTIS AG (US) | 2013-07-02 | — | — | US | disclosed |
| US-20090186830-A1 | MACROCYCLES AND THEIR USES | NOVARTIS AG (CH) | 2009-07-23 | — | — | US | disclosed |
| US-20090186830-A1 | MACROCYCLES AND THEIR USES | NOVARTIS AG (CH) | 2009-07-23 | — | — | US | disclosed |
| US-4356324-A | CHIRAL LIGANDS FOR RHODIUM HYDROGENATION CATALYSTS | DEGUSSA AKTIENGESELLSCHAFT, A GERMAN CORP. (DE) | 1982-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130252883-A1 | Macrocycles and Their Uses | MRPL21, CLPP, MLEC | GAA 557/4885ALDH1A1 3067/4885MEN1 1032/4885 |
| US-20090186830-A1 | MACROCYCLES AND THEIR USES | CYP11B2, OAT, CYP27A1 | GAA 232/4885ALDH1A1 877/4885MEN1 947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.